News

Chloroquine approved for Clinical Trials by NAFDAC…Get the details

Google+ Pinterest LinkedIn Tumblr

National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in tackling COVID-19.

Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.

She, however, pointed out that the agency is not approving Chloroquine for the treatment of  COVID-19 but for clinical trials to find treatment for the virus.

“In the case of Chloroquine, it has been demonstrated in the literature and with clinical research which is still ongoing, that Chloroquine is superior to the Placebo.

“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.

“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.

Meanwhile three International Airport has been shut down in Nigeria.

Source: Channels

Follow and like us on
Facebook: Gist Always
Twitter: @Gistalways
Instagram: @Gistalways
Subscribe on Youtube: Gistalways

Get live updates, exclusives, most inspiring and interesting gists on www.gistalways.ng

What do you think

%d bloggers like this: